Benralizumab
Product Specifications
CAS Number
1044511-01-4
Target
IL Receptor, Apoptosis, Interleukin
Related Pathways
Apoptosis, Immunology/Inflammation
Purity
>95%
Bioactivity
Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα) . It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1369278-01 0.02 mg (E-Coli)
Recombinant Pseudomonas syringae pv. phaseolicola Probable transcriptional regulatory protein PSPPH_3775 (PSPPH_3775)
Sign In for Pricing
View Details MBS1369278-02 0.1 mg (E-Coli)
Recombinant Pseudomonas syringae pv. phaseolicola Probable transcriptional regulatory protein PSPPH_3775 (PSPPH_3775)
Sign In for Pricing
View Details